NCT05503303View on ClinicalTrials.gov

T1D, Metabolic Syndrome and Insulin Resistance

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

February 15, 2022

Study Completion Date

March 1, 2022

Conditions
Type 1 DiabetesMetabolic SyndromeInsulin Resistance
Trial Locations (1)

86090

Isela Esther Juarez Rojop, Villahermosa

All Listed Sponsors
lead

Universidad Juárez Autónoma de Tabasco

OTHER

NCT05503303 - T1D, Metabolic Syndrome and Insulin Resistance | Biotech Hunter | Biotech Hunter